Value of biologic therapy: A forecasting model in three disease areas

Author： Paramore L. Clark   Hunter Craig A.   Luce Bryan R.   Nordyke Robert J.   Halbert R.J.  

Publisher： Informa Healthcare

ISSN： 1473-4877

Source： Current Medical Research and Opinion, Vol.26, Iss.1, 2010-01, pp. : 41-51

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Biologic Therapy in Immune Mediated Inflammatory Disease: Basic Science and Clinical Concepts

By  

Current Drug Safety, Vol. 11, Iss. 1, 2016-03 ,pp. : 35-43

Bentham Science Publishers

Access to resources Recommend Favorite

Biologic Therapy in Lupus Nephritis

By  

Nephron Clin Pract, Vol. 128, Iss. 3-4, 2015-0 ,pp. : 255-260

Karger

Access to resources Recommend Favorite

Biologic Markers in Alzheimer's Disease

By  

JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 33, Iss. 10, 1985-10 ,pp. : 715-726

John Wiley & Sons Inc

Access to resources Recommend Favorite

Biologic Treatment in Glomerular Disease

By  

Nephron Clin Pract, Vol. 128, Iss. 3-4, 2015-0 ,pp. : 203-204

Karger

Access to resources Recommend Favorite

Risks of Herpes Zoster in Patients With Rheumatoid Arthritis According to Biologic Disease‐Modifying Therapy

By  

ARTHRITIS CARE AND RESEARCH, Vol. 67, Iss. 5, 2015-05 ,pp. : 731-736

John Wiley & Sons Inc

Access to resources Recommend Favorite